白宫威胁 FDA 11 日批准新冠疫苗

白宫威胁 FDA 11 日批准新冠疫苗

人民日报海外网, 白宫11日威胁FDA批准新冠疫苗: otherwise the director should resign

The White House threatened the FDA Commissioner (左边) 11日批准新冠疫苗. (盖蒂图片社)

海外网络, 十二月 12, US media reported that White House Chief of Staff Mark Meadows told the US Food and Drug Administration (食品药品监督管理局) Commissioner Stephen Hahn on the 11th local time that if the agency ends on the same day If you have not approved the new crown vaccine developed by Pfizer for emergency use, please submit your resignation.

According to the “Washington Post” report on the 11th local time, this warning prompted FDA Commissioner Hahn and the agency to speed up the timetable for vaccine approval starting on Saturday (12th). The New York Times, Axios and Reuters also confirmed the news. Meadows told Hahn that if he does not act quickly to approve the vaccine, he will resign. 在同一天, US President Trump also issued threats. Trump posted on social media criticizing the FDA as a “large and slow turtle” in handling vaccines, and warned Hahn that “vaccinations should be taken out now” 和 “don’t play tricks with me, save lives.”

据报道, Meadows and Tron’s threats have increased pressure on Hahn and the FDA. Trump has complained that the vaccine was not approved before election day and accused him of “delaying” his re-election. 此外, Trump is dissatisfied that the United Kingdom approved the vaccine before the United States, although Pfizer vaccine has shortened the development and review time.

Hahn said in a statement on Friday (11th) that the FDA has informed Pfizer that after the agency’s advisory committee approved Pfizer’s vaccine on Thursday (10th), the agency will “quickly complete the final procedure and issue an emergency use authorization.” . 此外, the report pointed out that the FDA also notified the Centers for Disease Control and Prevention (CDC) 和 “Action Curvature Rapid” project, “so that they can execute the plan and distribute the vaccine in time.”

The US media criticized that this threat once again injected political factors into the vaccine competition, which may undermine public trust in vaccines. Since many people in the United States are still unsure whether they will be vaccinated, the vaccine approval process is to show that there are no shortcuts when reviewing the safety and effectiveness of the vaccine. (Overseas Network Hou Xingchuan)

This article is copyrighted work, unauthorized reproduction is strictly prohibited. For overseas vision and China’s position, visit the official website of the Overseas Edition of the People’s Daily-www.haiwainet.cn or the “Haike” client to get authoritative information one step ahead.